Misoprostol distribution

Summary of Qualitative Findings Table

Review question
What are to the barriers/gaps in the implementation of misoprostol use for prevention of postpartum
hemorrhage and management of Post-abortion care services in developing countries.

Authors of the review

Amir Ali Barket Ali Samnani, Narjis Rizvi Tazeen Saeed Ali, and Farina Abrejo

Corresponding author
Amir Ali Barket Ali Samnani - am_samnani@hotmail.com

Has the review been published?

| DOI:

Additional Information

GRADE-CERQual Explanation of
Summarised review
# Assessment of GRADE-CERQual References
finding
confidence Assessment

1. LEADERSHIP, GOVERNANCE, AND POLICY

1 Licencing was Osur J et al. 2013; Starrs A
& Winikoff B 2012; Moore
absent as most JE et al. 2016; Sheldon WR
countries or et al. 2014;
ministries did not
have misoprostol
registered or
lincenced for the
management of PAC
or PPH. Our focus
was on prevention of
PPH. There was also
limited
understanding of
existing policy.
2 Implementers did not Starrs A & Winikoff B 2012;
Spangler SA et al. 2014;
have clarity, with Haver J et al. 2016; Smith
fear and confusion JM et al. 2014; Sheldon WR
among some et al. 2014; Vogel JP et al.
2016;
implementing
partners. This limited
integration of
distribution of
misoprostol into
routine health
services in the health
facilities. There were
also technical
ambiguity, with out
clarity in the
 GRADE-CERQual Explanation of
Summarised review
# Assessment of GRADE-CERQual References
finding
confidence Assessment

guidelines. This was

exarcebated by poor
communication and
transportation. As a
result, only a few
countires had
implemented pilot
studies, which have
not been scaled
nationally.
Evidence Profile Table

GRADE-CERQual
Summarised review Methodological
# Coherence Adequacy Relevance assessment of References
finding limitations
confidence

1. LEADERSHIP, GOVERNANCE, AND POLICY

1 Licencing was Moore JE et al. 2016;
Osur J et al. 2013;
absent as most Sheldon WR et al. 2014;
countries or Starrs A & Winikoff B
ministries did not 2012;

have misoprostol
registered or
lincenced for the
management of
PAC or PPH. Our
focus was on
prevention of PPH.
There was also
limited
understanding of
existing policy.
2 Implementers did Haver J et al. 2016;
Sheldon WR et al. 2014;
not have clarity, Smith JM et al. 2014;
with fear and Spangler SA et al. 2014;
confusion among Starrs A & Winikoff B
2012; Vogel JP et al.
some 2016;
implementing
partners. This
limited integration
of distribution of
misoprostol into
routine health
services in the
health facilities.
There were also
 GRADE-CERQual
Summarised review Methodological
# Coherence Adequacy Relevance assessment of References
finding limitations
confidence

technical
ambiguity, with
out clarity in the
guidelines. This
was exarcebated by
poor
communication
and transportation.
As a result, only a
few countires had
implemented pilot
studies, which
have not been
scaled nationally.